|
| | 
|
 | |
        
|  |
|  |
|
 Abbott Laboratori - [Ticker: ABT] |     | | Last Trade | 73.26 | Last Trade Time | 2018-11-29 - 00:00:00 | | Variation | +0.43 (+1.01%) | Open | 72.43 | | High | 73.70 | Low | 72.37 | | Volume | 6,399,884 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 54.24 x 1,400 - 54.25 x 400 | | Former Close | 72.83 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about Abbott Laboratori: | | No topics about Abbott Laboratori [ABT] have been found, but a search on the Forum for more topics related to Abbott Laboratori is advised. |
|
News about Abbott Laboratori [ABT]: (ordered by relevance)
| Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable Nasdaq
- Lawmakers grill U.S. FDA on response to Abbott baby formula safety Reuters.com
- Abbott should continue baby formula rebates throughout 2022 - Senators (NYSE:ABT) Seeking Alpha
- Baby Formula Shortage: Abbott (ABT) Tax Practices Under Investigation by Senator Bloomberg
- Abbott CEO apologizes for baby formula shortage, promises production ramp-up MarketWatch
- U.S. baby formula shortage: FDA defends response, cites safety problems at Abbott plant Nasdaq
Abbott to restart production of EleCare formula on June 4 MarketWatch
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties ? ABT GlobeNewswire
Despite 'lost confidence' in Abbott, FDA OKd baby formula plant reopening Seeking Alpha
Abbott in Pact With FDA on Steps to Reopen Baby-Formula Plant Bloomberg
Baby Formula Shortage: Abbott (ABT) Factory Bacteria Risk Spotted Last Year Bloomberg
Baby formula crunch in U.S. forces scramble to boost supplies Reuters.com
Here's Why Investors Should Retain Abbott (ABT) Stock Now Nasdaq
Abbott: Solid Conviction Pick Seeking Alpha
Abbott to release certain batches of baby formulas (NYSE:ABT) Seeking Alpha
Abbott in focus as U.S. lawmakers grill FDA chief over baby formula shortage (NYSE:ABT) Seeking Alpha
Abbott (ABT) Stock: $125 Price Target And Buy Rating Pulse 2.0
Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment Corporation PR Newswire
Abbott Laboratories (NYSE:ABT) Receives Consensus Recommendation of ?Buy? from Brokerages Defense World
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise PR Newswire
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes PR Newswire
First baby formula shipment arrives in U.S. from Europe Reuters.com
Analysts Expect Abbott Laboratories (NYSE:ABT) to Post $1.11 Earnings Per Share Defense World
Top Analyst Reports for Visa, Walt Disney & Abbott Nasdaq
Better Dividend King: Johnson & Johnson vs. Abbott Laboratories The Motley Fool
Danone boosts baby formula shipments to U.S. after Abbott recall (OTCMKTS:DANOY) Seeking Alpha
Danone, Reckitt race to ramp up US baby formula supply amid shortage ? PharmaLive PharmaLive
U.S. lawmakers launch probe into baby formula shortage (NYSE:ABT) Seeking Alpha
Dexcom Stock Yo-Yoes As Investors Digest Potential Diabetes Merger With Insulet Investor's Business Daily
Here's the Worst News for Abbott Right Now (and Why Investors Shouldn't Worry) The Motley Fool
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months PR Newswire
ABT: 5 Buy-Rated Healthcare Stocks Trading Near 52-Week Lows to Scoop Up Right Now StockNews.com
FDA expects baby formula shortage to improve in 'next couple of months' Yahoo Canada Finance
Abbott Strengthens Left Atrial Appendage Closure Leadership With US Availability of Amplatzer? Steerable Delivery Sheath for the Company's Amulet? Device PR Newswire
Abbott to Release Metabolic Nutrition Formulas Yahoo Finance
Abbott launches Xience Skypoint drug-eluting stent in extended sizes Drug Delivery Business News
The Global Cardiac Resynchronization Therapy Market is Expected to Grow at a CAGR of 10.82% During the Forecast Period from 2022 to 2027 | DelveInsight Medgadget
Interventional Cardiology and Peripheral Vascular Devices Market Key Vendors, Opportunities, Deep Analysis By Regional & Country Outlook | Medtronic, CR Bard, Boston Scientific, Abbott Laboratori? ? The Daily Vale The Daily Vale
AUVI: Is Applied UV Stock a Good Stock to Own in 2022? StockNews.com
DexCom Inc. stock falls Wednesday, underperforms market MarketWatch
Experts suggest using WIC government benefits to get baby formula amid a nationwide shortage ? but these frustrated parents say that?s not a viable option MarketWatch
Baby formula shortage: What not to do, according to a former FDA official Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors MarketWatch
Wall Street Breakfast: Blood In The Streets Seeking Alpha
Hologic Inc. stock outperforms market despite losses on the day MarketWatch
Medtronic PLC stock rises Tuesday, outperforms market MarketWatch
Catalyst Pharmaceuticals Inc. stock falls Tuesday, still outperforms market MarketWatch
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript The Motley Fool
Abbott: Closing The Gap On Industry Leader Seeking Alpha
(ABT Alert) Long Term Holders of Abbott Laboratories Contact Johnson Fistel for Information Regarding Investigation GlobeNewswire
This Medical Devices Company Is A Better Pick Over Abbott Stock Forbes
FDA Commissioner Califf to testify on baby formula shortage at House hearing Thursday Seeking Alpha
Abbott Plans to Launch Health Wearables Outside the U.S. Later This Year Bloomberg
Rise in COVID-19 Test Demand to Boost Abbott (ABT) Q4 Earnings Yahoo Finance
Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant FDA.gov
Abbott Beats on Profit, Revenue Despite Virus Testing Drop Bloomberg
Here's Why You Should Retain Abbott (ABT) Stock For Now Nasdaq
Abbott Announces Future of Biowearables at Consumer Electronics Show PR Newswire
Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript) Seeking Alpha
Abbott Falls After Cutting 2021 Profit Forecast as Testing Slows Bloomberg
Top Stock Reports for Alibaba, McDonald's & Advanced Micro Devices Zacks Investment Research
Guidewire (GWRE) Insurtech Vanguards Platform Boasts 25 Members Nasdaq
3 Things About Abbott Laboratories That Smart Investors Know The Motley Fool
Abbott Laboratories Stock (ABT): Why The Price Increased Pulse 2.0
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast Press Releases
Abbott (ABT) Introduces New Next-Generation Infant Formula Nasdaq
Abbott CardioMEMS HF System gains expanded heart failure indication (NYSE:ABT) Seeking Alpha
Inorganic Growth Efforts Aid Schwab (SCHW) Amid Cost Concerns Nasdaq
ABT stock in focus as China warns against products after U.S. recall (ABT) Seeking Alpha
Will Higher Costs Continue to Mar Gap's (GPS) Earnings in Q1? Nasdaq
Abbott CEO Apologizes for Company's Role in Baby Formula Shortage The Wall Street Journal
Here's Why Investors Should Buy Argo Group (ARGO) Stock Now Nasdaq
Abbott Declares 393rd Consecutive Quarterly Dividend - Feb 18, 2022 Press Releases
Abbott Laboratories (NYSE:ABT) Receives Average Rating of ?Buy? from Analysts Defense World
Abbott Laboratories (ABT) Company Profile, News, Rankings | Fortune Fortune
ABT: Abbott Laboratories vs. Zimmer Biomet Holdings: Which Medical Device Stock is a Better Buy? StockNews.com
Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 14, 2021 Nasdaq
Brokerages Anticipate Abbott Laboratories (NYSE:ABT) Will Announce Earnings of $1.47 Per Share Defense World
Abbott Labs CEO expects strong COVID-19 testing demand in near term Reuters.com
Should You Be Adding Abbott Laboratories (NYSE:ABT) To Your Watchlist Today? Simply Wall St
Abbott Laboratories (NYSE:ABT) Expected to Post Quarterly Sales of $10.33 Billion Defense World
Abbott Ireland Financing DAC -- Moody's upgrades Abbott Laboratories senior unsecured rating to A1 Yahoo Finance
Abbott Receives FDA Approval for Aveir? VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms Press Releases
The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp Yahoo Finance
ABT or RMD: Which Is the Better Value Stock Right Now? Nasdaq
Abbott Announces World's First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial PR Newswire
2022-04-25 | NYSE:ABT | Press Release | ABBOTT LABORATORIES Stockhouse
If You Invested $1000 In Abbott Laboratories 5 Years Ago, Here's How Much You Would Have Today - Benzinga Benzinga
Abbott Explains Why It Built in Indiana ? Inside INdiana Business Inside INdiana Business
Abbott's Proclaim? XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in US PR Newswire
Abbott, Boston Scientific, Medtronic most likely ShockWave Medical buyers - analyst Seeking Alpha
Integral Health Asset Management, LLC Buys McKesson Corp, Centene Corp, Abbott Laboratories, ... Yahoo Finance
Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI) PR Newswire
Abbott Labs to pay $160 mln over kickbacks, false diabetes claims to Medicare Reuters
Abbott Laboratories' (ABT) CEO Robert Ford on Q3 2021 Results - Earnings Call Transcript Seeking Alpha
Abbott to Cut Ribbon on Westfield Manufacturing Plant ? Inside INdiana Business Inside INdiana Business
Abbott Laboratories Is Priced For Perfection Seeking Alpha
This May Be Abbott's Billion-Dollar Opportunity The Motley Fool
3 Reasons to Buy This Newly Minted Dividend King The Motley Fool
Wednesday Is Your Last Chance To Buy Abbott Laboratories Before The Dividend Payout - Benzinga Benzinga
Abbott says at-home COVID tests will be widely available again by end of October Yahoo Finance
Abbott, Big Pharma companies aren't exiting Russia Crain's Chicago Business
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial PR Newswire
2 Top Healthcare Stocks to Buy Right Now The Motley Fool
| For more news about Abbott Laboratori click here:
Abbott Laboratori News |
|
Website Width:
Background image: |
|  | |
|
|
![Abbott Laboratori - [Ticker: ABT] chart](http://www.tr4der.com/chart/tr4der-ABT-5-years.png)
